
Pharmaceuticals are rebounding as U.S. drug pricing clarity emerges, shifting focus to patent expirations and innovation-driven differentiation. Companies like JNJ and AZN, with diversified portfolios
Diageo PLC (LSE:DGE) has appointed former Procter & Gamble Beauty chief executive R. Alexandra “Alex” Keith as a non-executive director, adding more than 35 years of international consumer goods exper

Thermo Fisher Scientific is rated a Buy, supported by accelerating organic growth and improving Pharma and Biotech end markets. TMO's recent acquisitions of Clario and Solventum's Filtration and Separ
Thermo Fisher Scientific NYSE: TMO reported stronger-than-expected second-quarter 2026 results and raised its full-year outlook, citing improving customer activity across end markets, broad-based grow

In a year already marked by headlines of Ebola outbreaks and flashback-inducing cruise ship quarantines, everyday foodborne threats are delivering a sharp reminder of supply chain vulnerability. Since